EDGC
245620KOSDAQ자연과학 및 공학 연구개발업63.5 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
EDGC is a global bio-genomics big data company established in 2013 as a joint venture between a Korean medical institution and the U.S.-based Diagnomics, Inc. It offers key services such as NGS-based genomic analysis, personalized diagnostic tests, and liquid biopsy (OncoCatch), along with its flagship services 'YouWho' for genetic ancestry analysis and 'NICE' for non-invasive prenatal testing. In 2021, EDGC acquired a Canadian health supplement manufacturer to expand its customized health supplement business, aiming to develop integrated precision medicine solutions through genomic-based drug development.
Number of Employees
63people
Average Salary
43.6M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Half of industry avg (excellent)
Avg ▼69.8% (2-year basis)
Avg ▲26.2% (2-year basis)
Avg ROE -150.7% (declining, 2yr)
Detailed News Sentiment
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Positive[기재정정]주요사항보고서(유상증자결정)2026-05-26
- Neutral[기재정정]주요사항보고서(감자결정)2026-05-26
- Positive[기재정정]주요사항보고서(유상증자결정)2026-05-26
- Positive[기재정정]주요사항보고서(유상증자결정)2026-05-22
- Neutral[기재정정]주요사항보고서(감자결정)2026-05-22
